MINGCHEN HEALTH Co (002919.SZ) Stock Price
MINGCHEN HEALTH Co Price
Revenue has compounded at 11.1% per year over the past 12 years to 1.51 B CNY. Earnings per share have grown at 2.5% per year over the last 12 years. MINGCHEN HEALTH Co's net margin stands at 1.9%, down from 17.9% several years earlier. MINGCHEN HEALTH Co currently offers a dividend yield of about 0.31%. The payout ratio is around 47% of earnings.
MINGCHEN HEALTH Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
MINGCHEN HEALTH Co business model & stock analysis
Frequently asked questions about MINGCHEN HEALTH Co
6 analysts currently rate the MINGCHEN HEALTH Co stock: 5 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the MINGCHEN HEALTH Co share trades at 2.16 EUR (16.23 CNY).
The MINGCHEN HEALTH Co share (002919.SZ) is listed on 1 stock exchanges, including: Shenzhen (002919.SZ).
The revenue cannot currently be calculated for MINGCHEN HEALTH Co.
The profit cannot currently be calculated for MINGCHEN HEALTH Co.
The P/E ratio cannot be calculated for MINGCHEN HEALTH Co at the moment.
The P/S cannot be calculated for MINGCHEN HEALTH Co currently.
The Eulerpool Quality Score for MINGCHEN HEALTH Co is 6/10.
The ISIN of MINGCHEN HEALTH Co is CNE1000033B9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of MINGCHEN HEALTH Co is 002919.SZ. The ticker symbol is used to trade MINGCHEN HEALTH Co shares on the stock exchange.
MINGCHEN HEALTH Co stock
MINGCHEN HEALTH Co Peer Group
MINGCHEN HEALTH Co Ticker
MINGCHEN HEALTH Co FIGI
All fundamentals and in-depth analysis of MINGCHEN HEALTH Co
Our stock analysis for MINGCHEN HEALTH Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MINGCHEN HEALTH Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.